Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Daiichi Sankyo

    Tag: daiichi sankyo

    You Searched For "Daiichi Sankyo"
    Fortis investors move SEBI over delay in IHH open offer, ask for interest: Report

    Fortis investors move SEBI over delay in IHH open offer, ask for interest: Report

    Meghna A Singhania23 May 2019 5:22 PM IST
    New Delhi: Displeased with delay in an open offer to buy an additional stake, a few of the shareowners holding minor shares of Fortis Healthcare Ltd...
    SEBI asks Fortis to recover Rs 403 crore from Singh Brothers; FHL informs HC

    SEBI asks Fortis to recover Rs 403 crore from Singh Brothers; FHL informs HC

    Meghna A Singhania15 May 2019 12:20 PM IST
    Fortis made the submission in a recent affidavit filed in an ongoing case by Japanese drugmaker Daiichi Sankyo against the Singh brothers and their...
    Fortis tightens financial noose around Singh brothers; likely to move Delhi HC

    Fortis tightens financial noose around Singh brothers; likely to move Delhi HC

    Farhat Nasim11 May 2019 5:43 PM IST
    New Delhi: Surrounded by controversies, Singh brothers is likely to face judicature as Fortis Healthcare Ltd (FHL) plans to a reach out to the Delhi...
    AstraZeneca, Daiichi Sankyo breast cancer drug Trastuzumab Deruxtecan shows promise

    AstraZeneca, Daiichi Sankyo breast cancer drug Trastuzumab Deruxtecan shows promise

    Medical Dialogues Bureau10 May 2019 9:00 AM IST
    The treatment Trastuzumab Deruxtecan, or DS-8201, demonstrated a clinically meaningful response in patients with refractory HER2-positive metastatic...
    AstraZeneca Q1 sales beat estimates on cancer drugs

    AstraZeneca Q1 sales beat estimates on cancer drugs

    Garima28 April 2019 9:15 AM IST
    AstraZeneca, fresh off an oncology deal with Japan's Daiichi Sankyo Co Ltd, in February reported annual sales growth for the first time since 2009,...
    Ranbaxy Case: Singh Brothers diverted funds despite SC orders, alleges Daiichi

    Ranbaxy Case: Singh Brothers diverted funds despite SC orders, alleges Daiichi

    Medical Dialogues Bureau12 April 2019 2:30 PM IST
    "Their nearly Rs 6,300 crore has been syphoned off by some 'baba'. These children have been duped," Kapil Sibal had said, adding that let the...
    Insider trading: Sun Pharma Senior Executive, wife pay over Rs 70 lakh settlement to SEBI

    Insider trading: Sun Pharma Senior Executive, wife pay over Rs 70 lakh settlement to SEBI

    Meghna A Singhania12 April 2019 10:59 AM IST
    Abhay Arvind Gandhi and his wife traded in Ranbaxy shares soon after Japanese major Daiichi, in 2014, agreed to sell Ranbaxy to Sun Pharma. New Delhi:...
    AstraZeneca, Daiichi Sankyo sign $6.9 billion cancer drug deal

    AstraZeneca, Daiichi Sankyo sign $6.9 billion cancer drug deal

    Garima29 March 2019 9:15 AM IST
    Under the deal, AstraZeneca will pay Daiichi up to $6.9 billion, including a $1.35 billion upfront payment. The two companies will share development...
    Supreme court directs former Ranbaxy promoters to appear on March 14

    Supreme court directs former Ranbaxy promoters to appear on March 14

    Garima28 Feb 2019 9:30 AM IST
    "The court would like to have the personal presence of respondent nos. 2 and 4 (Malvinder and Shivinder Singh) in SLP(C) No... along with their...
    Fortis Brothers Feud: Malvinder accuses brother Shivinder of death threats, files criminal complaint

    Fortis Brothers Feud: Malvinder accuses brother Shivinder of death threats, files criminal complaint

    Farhat Nasim18 Feb 2019 11:46 AM IST
    New Delhi: The public fight between the former billionaire brothers, Malvinder Singh and Shivinder Mohan Singh has turned all the more dramatic as the...
    Supreme Court refuses interim order on sale of Fortis shares to IHH; final hearing on February 26

    Supreme Court refuses interim order on sale of Fortis shares to IHH; final hearing on February 26

    Medical Dialogues Bureau16 Feb 2019 12:33 PM IST
    A bench comprising Chief Justice Ranjan Gogoi and Justice Sanjiv Khanna said that it would accord final hearing in the case on February 26.New Delhi:...
    Singh brothers took 78 million dollars out of Fortis: Report

    Singh brothers took 78 million dollars out of Fortis: Report

    Ruby Khatun Khatun10 Feb 2018 11:13 AM IST
    India's tycoon Singh brothers took at least Rs 500 crore ($78 million) out of the publicly-traded hospital company they control without board approval...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok